CIRS Group
Medical Devices
C&K Testing
Carbon Neutrality

ECHA Proposed to Identify N-(hydroxymethyl)acrylamide as SVHC

from CIRS by


On 4 Mar. 2022, ECHA has released a proposal on identifying N-(hydroxymethyl)acrylamide as a substance of very high concern for its carcinogenicity (Article 57a) and mutagenicity (Article 57b). This proposal is still under public consultations, interesting parties may send their comments to ECHA before 19 Apr. 2022.

The substance will be added into the SVHC Candidate List after it passes the public consultation.

Detailed information of the substance: 

Name of Substance

EC No.


Proposing Authority

Reason for Proposing





Carcinogenic (Article 57a);

Mutagenic (Article 57b)


The Candidate List includes substances of very high concern that may have serious effects on human health or environment. These may be placed on the Authorisation List in the future, which means that industry would need to apply for permission to continue using them. Companies may have legal obligations when their substance is included in the Candidate List - either on its own, in mixtures or in articles. Any supplier of articles containing a Candidate List substance above a concentration of 0.1 % weight by weight has to give sufficient information to their customers and consumers to allow safe use.

If you have any needs or questions, please contact us at

Further Information

Substance of Very High Concern Identification

SVHC Notification

The SVHC Candidate now Contains 223 Substances


We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Contact Us
+353 1 477 3710 (EU)
+44 20 3239 9430 (UK)
+1 703 520 1420 (USA)
+86 571 8720 6574 (CN)
+82 2 6347 8816 (KR)